Related stories
Bristol Myers Squibb Raises 2026 Revenue Guidance, Cuts EPS Outlook
Bristol Myers Squibb raised full-year 2026 revenue guidance to $49.75 billion–$50.25 billion from $49 billion–$50 billion, while lowering non-GAAP EPS guidance to $6.35–$6.55 from
M impact | EARNINGS | Nov 02, 2026, 04:02 PM UTC
Mermeren Kombinat Reports 9M Sales of EUR €12.9M
Mermeren Kombinat's nine-month sales were EUR €12.9 million, compared with €22.6 million a year earlier.
M impact | EARNINGS | Nov 02, 2026, 04:01 PM UTC
Estée Lauder Cuts Promotions as Luxury Fragrances Lift Outlook
M impact | EARNINGS | Nov 02, 2026, 03:56 PM UTC
West Fraser Expects 2026 Lumber, North American OSB Shipments at Low End of Guidance
M impact | EARNINGS | Nov 02, 2026, 03:46 PM UTC
S-Oil Profit Rises Nearly 23-Fold in Third Quarter
S-Oil’s profit rose nearly 23-fold in the third quarter.
M impact | EARNINGS | Nov 02, 2026, 03:42 PM UTC
Convergenze Reports Nine-Month Revenue of EUR 21.3 Million, Up 11.1%
M impact | EARNINGS | Nov 02, 2026, 03:36 PM UTC